Systemic lupus erythematosus-associated catastrophic antiphospholipid syndrome occurring after typhoid fever: A possible role of Salmonella lipopolysaccharide in the occurrence of diffuse vasculopathy-coagulopathy

Arthritis and Rheumatism

Volumn 42, Issue 5, 1999, Pages 1056-1061

  Hayem, Gilles ^a,c   Kassis, Najiby ^a   Nicaise, Pascale ^a   Bouvet, Philippe ^b   Andremont, Antoine ^a   Labarre, Colette ^a   Kahn, Marcel Francis ^a   Meyer, Olivier ^a  

^a Section of Radiology   (France)

^b INSTITUT PASTEUR   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE;

ADULT; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CORTICOSTEROID THERAPY; FEMALE; GLOMERULONEPHRITIS; HUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; SALMONELLA TYPHI; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT FAILURE; TYPHOID FEVER;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION DISORDERS; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; LUPUS ERYTHEMATOSUS, SYSTEMIC; SALMONELLA TYPHI; TYPHOID FEVER; VASCULAR DISEASES;

EID: 0032960660     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199905)42:5<1056::AID-ANR27>3.0.CO;2-I     Document Type: Article

References (15)

1. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992;19:508-12.
2. Kitchens CS. Thrombotic storm: when thrombosis begets thrombosis. Am J Med 1998;104:381-5.
3. Asherson RA, Cervera R, Piette JC, Font J, Lie JT, Burcoglu A, et al. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998;77:195-207.
4. Neuwelt CM, Daikh DI, Linfoot JA, Pfister DA, Young RG, Webb RL, et al. Catastrophic antiphospholipid syndrome: response to repeated plasmapheresis over three years. Arthritis Rheum 1997;40:1534-9.
5. Westphal O, Janne K. Bacterial lipopolysaccharides: extraction with phenol-water and further application of the procedure. Methods Carbohydrate Chem 1965;5:80-91.
6. Drenkard C, Sanchez-Guerrero J, Alarcon-Segovia D. Fall in antiphospholipid antibody at time of thromboocclusive episodes in systemic lupus erythematosus. J Rheumatol 1989;16:614-7.
7. Golden BD, Belmont HM. The role of microvasculopathy in the catastrophic antiphospholipid syndrome: comment on the article by Neuwelt et al [letter]. Arthritis Rheum 1998;41:751-3.
8. Pablos JL, Aragon A, Gomez-Reino JJ. Salmonellosis and systemic lupus erythematosus: report of ten cases. Br J Rheumatol 1994;33:129-32.
9. Li EK, Cohen MG, Ho AK, Cheng AF. Salmonella bacteraemia occurring concurrently with the first presentation of systemic lupus erythematosus. Br J Rheumatol 1993;32:66-7.
10. Gotoh M, Matsuda J. Induction of anticardiolipin antibody and/or lupus anticoagulant in rabbits: immunization with lipoteichoic acid, lipopolysaccharide and lipid A. Lupus 1996;5:593-7.
11. Granholm NA, Cavallo T. Enhancement of renal disease in BXSB lupus prone mice after prior exposure to bacterial lipopolysaccharide. Lupus 1995;4:339-47.
12. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R, et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 1997;186:1831-41.
13. Belmont HM, Abramson SB, Lie JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interactions of inflammatory cells and activated endothelium. Arthritis Rheum 1996;39:9-22.
14. Pradier O, Gerard C, Delvaux A, Lybin M, Abramowicz D, Capel P, et al. Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol 1993;23:2700-3.
15. Reverter J-C, Tàssies D, Font J, Khamashta MA, Ichikawa K, Cervera R, et al. Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. Arthritis Rheum 1998;41:1420-7.